|
|
| Author |
Message |
ironjustice@aol.com medicine forum Guru
Joined: 28 Apr 2005
Posts: 1522
|
Posted: Mon May 23, 2005 9:01 pm Post subject:
Accumulation of iron / breast cancer
|
|
|
Free Radic Biol Med. 1999 Feb;26(3-4):348-54. Related Articles, Links
Alcohol-induced breast cancer: a proposed mechanism.
Wright RM, McManaman JL, Repine JE.
Webb-Waring Antioxidant Research Institute and University of Colorado
Health Sciences Center, Denver 80262, USA. richard.m.wright@uchsc.edu
Alcohol consumption increases the risk for breast cancer in women by
still undefined means. Alcohol metabolism is known to produce reactive
oxygen species (ROS), and breast cancer is associated with high levels
of hydroxyl radical (*OH) modified DNA, point mutations, single strand
nicks, and chromosome rearrangement. Furthermore, ROS modification of
DNA can produce the mutations and DNA damage found in breast cancer.
Alcohol dehydrogenase (ADH) and xanthine oxidoreductase (XOR) are
expressed and regulated in breast tissues and aldehyde oxidase (AOX)
may be present as well. Mammary gland XOR is an efficient source of
ROS. Recently, hepatic XOR and AOX were found to generate ROS in two
ways from alcohol metabolism: by acetaldehyde consumption and by the
intrinsic NADH oxidase activity of both XOR and AOX. The data obtained
suggests that: (1) expression of ADH and XOR or AOX in breast tissue
provides the enzymes that generate ROS; (2) metabolism of alcohol
produces acetaldehyde and NADH that can both be substrates for XOR or
AOX and thereby result in ROS formation; and (3) ROS generated by XOR
or AOX can induce the carcinogenic mutations and DNA damage found in
breast cancer. Accumulation of iron coupled with diminished antioxidant
defenses in breast tissue with advancing age provide additional support
for this hypothesis because both result in elevated ROS damage that may
exacerbate the risk for ROS-induced breast cancer.
Publication Types:
Review
Review, Tutorial
PMID: 9895226 [PubMed - indexed for MEDLINE]
--------------------------------------------------------------------------------
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivore
DEAD PEOPLE WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking |
|
| Back to top |
|
 |
ironjustice@aol.com medicine forum Guru
Joined: 28 Apr 2005
Posts: 1522
|
Posted: Mon May 23, 2005 9:13 pm Post subject:
Re: Accumulation of iron / breast cancer
|
|
|
| Quote: | snip
Triapine is currently in phase II clinical trial as an anticancer agent
snip
|
Curr Med Chem. 2003 Jun;10(12):983-95. Related Articles, Links
Iron chelator research: past, present, and future.
Tam TF, Leung-Toung R, Li W, Wang Y, Karimian K, Spino M.
Medicinal Chemistry Department, Apotex Research, Inc., 400 Ormont
Drive, Toronto, Ontario, Canada. ttam@apotex.com
The occurrence of in vivo iron toxicity in the human body can be
categorized into iron overload and non-iron overload conditions. Iron
overload conditions are common in beta-thalassemia and hereditary
hemochromatosis patients, and anthracycline mediated cardiotoxicity is
an example of a non-iron overload condition in cancer patients, in
which the toxicity is iron-dependent. While hundreds of iron chelators
have been evaluated in animal studies, only a few have been studied in
humans. Examples of iron chelator drugs are desferrioxamine (DFO),
deferiprone (L1), and dexrazoxane (ICRF 187). The compound ICL670 has
completed phase II clinical trials and a phase III trial is planned in
2003. Triapine is currently in phase II clinical trial as an anticancer
agent. CP502, GT56-252, NaHBED, and MPB0201 are examples of new
chelators in preclinical/clinical development. In the past decade, many
new viable utilities for iron chelators have been reported. This
includes the use of iron chelators as antiviral, photoprotective,
antiproliferative, and antifibrotic agents. This review will focus on
the status of drug development for the treatment of iron overload in
patients with beta-thalassemia and the potential use of iron chelators
in the prevention and treatment of other diseases.
Publication Types:
Review
PMID: 12678671 [PubMed - indexed for MEDLINE]
--------------------------------------------------------------------------------
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://pages.ivillage.com/ironjustice/manisaherbivoreDEAD PEOPLE
WALKING
http://pages.ivillage.com/ironjustice/deadpeoplewalking |
|
| Back to top |
|
 |
ironjustice@aol.com medicine forum Guru
Joined: 28 Apr 2005
Posts: 1522
|
|
| Back to top |
|
 |
Google
|
|
| Back to top |
|
 |
|
|
The time now is Mon Dec 01, 2008 7:49 pm | All times are GMT
|
|
Yahoo Personals Coupons | Remortgages | Record Songs for free | Mortgage Loans | MySpace Games
|
|
Copyright © 2004-2005 DeniX Solutions SRL
|
|
Other DeniX Solutions sites:
electronics forum,
Science forum
Unix/Linux blog
Unix/Linux documentation
Unix/Linux forums
|
Powered by phpBB © 2001, 2005 phpBB Group
|
|